Viking Global Investors Lp Editas Medicine, Inc. (EDIT) insider trading activity

Viking Global Investors LP is > 10% Shareholder of Editas Medicine, Inc.. Currently has a direct ownership of 266,782 shares of EDIT, which is worth approximately $328,141. The most recent transaction as insider was on Feb 08, 2015, when has been sold 1,020,407 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 267K

0% 3M change

0% 12M change

Total Value Held $328,141

VIKING GLOBAL INVESTORS LP Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 08 2015	BUY Open market or private purchase	-	1,020,407 Added 79.27%	266,782 Common Stock
Feb 08 2015	BUY Conversion of derivative security	-	1,709,401 Added 50.0%	1,709,401 Common Stock

Also insider at

Wayfair Inc. Consumer Cyclical

> 10% Shareholder

FDC

FIRST DATA CORP

> 10% Shareholder

ABUS

Arbutus Biopharma Corp Healthcare

> 10% Shareholder

MYOV

Myovant Sciences Ltd. Healthcare

> 10% Shareholder

SIOX

Sio Gene Therapies Inc. Healthcare

> 10% Shareholder

UROV

Urovant Sciences Ltd.

> 10% Shareholder

BBIO

BridgeBio Pharma, Inc. Healthcare

ADPT

Adaptive Biotechnologies Corp Healthcare

> 10% Shareholder

DNA

Ginkgo Bioworks Holdings, Inc. Healthcare

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

INBX

Inhibrx, Inc. Healthcare

FDMT

4D Molecular Therapeutics, Inc. Healthcare

RLYB

Rallybio Corp Healthcare

FIGS

FIGS, Inc. Consumer Cyclical

> 10% Shareholder

PRCT

PROCEPT BioRobotics Corp Healthcare

APG

APi Group Corp Industrials

AMLX

Amylyx Pharmaceuticals, Inc. Healthcare

RYZB

RayzeBio, Inc.

FLAC

Frazier Lifesciences Acquisition Corp Financial Services

ROIV

Roivant Sciences Ltd. Healthcare

VGI